A team of scientists led by Etienne Koechlin, Director of the Cognitive Neuroscience Laboratory (Inserm/ENS), has just decoded the reasoning process behind the human ability to adapt.
A study, carried out on mice, has just confirmed the neurobiological origin of attention - deficit disorder (ADD), a syndrome whose causes are poorly understood.
Researchers at Inserm and University of Lille 2/University of Lille Nord de France directed by David Blum, Inserm Research Fellow, have provided experimental evidence of the beneficial effects of caffeine in an animal model of Alzheimer’s disease. This work, carried out on mice and published in Neurobiology of Aging, supports the idea that caffeine has a protective effect in some brain pathologies.
The team led by Hélène Puccio, director of research for Inserm at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) (Inserm / CNRS / University of Strasbourg) in close collaboration with Patrick Aubourg’s team (Inserm and Professor of Neuropaediatrics at Bicêtre Hospital) has demonstrated, in the mice, the efficacy of gene therapy for […]
From birth, babies already have a representation of space, time and number. This has been proven by Dr Maria Dolores de Hevia, Dr Véronique Izard, Aurélie Coubart, Professor Elizabeth Spelke and Professor Arlette Streri from the Psychology and Perception Laboratory (Paris Descartes University/CNRS/Inserm) in a study published in PNAS.
Who would have thought that our brains are better equipped to process cognitive tasks if we are exposed to light several hours beforehand
Some people remember their dreams every morning, whereas others rarely remember them. A team led by Perrine Ruby, an Inserm Researcher has studied the brain activity of these types of dreamers in order to understand the differences between them.
A research team led by Giovanni Marsicano has succeeded in elucidating how the endocannabinoid system controls food intake through its effects on the perception of smells.
In an article published in Science, the researchers demonstrate that chloride levels are elevated in the neurons of mice used in an animal model of autism, and remain at abnormal levels from birth.
A French and English team (AP-HP, Inserm, UPEC, CEA/Mircen, Oxford Biomedica, Cambridge University) has conducted a clinical phase 1/2 gene therapy study among patients suffering from an evolved form of Parkinson’s disease. Fifteen patients were able to benefit from this new treatment, which involves injecting a vector expressing the genes of three enzymes that are essential for the biosynthesis of dopamine, which is lacking in Parkinson’s disease. Thanks to...